Alpha Square Group S, LLC Rani Therapeutics Holdings, Inc. Transaction History

Alpha Square Group S, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.98 - $3.8 $76,124 - $97,071	-25,545 Reduced 43.34%	33,401 $103,000
Q4 2023 Feb 14, 2024	SELL	$1.85 - $3.67 $51,800 - $102,760	-28,000 Reduced 32.2%	58,946 $195,000
Q3 2023 Nov 14, 2023	SELL	$2.17 - $4.44 $31,740 - $64,943	-14,627 Reduced 14.4%	86,946 $188,000
Q1 2023 May 15, 2023	SELL	$5.07 - $6.89 $152 - $206	-30 Reduced 0.03%	101,573 $524,000
Q4 2021 May 13, 2022	BUY	$16.09 - $35.0 $1.63 Million - $3.56 Million	101,603 New	101,603 $1.66 Million

3.68M

44K

193K

Ticker RANI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,492,000
Market Cap $35.5M
Description
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...

Get notified when there are updates to the investment portfolio of Alpha Square Group S, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Square Group S, LLC with notifications on news.